A model to evaluate the cost-effectiveness of oral therapies in the management of patients with major depressive disorders.

[1]  M. Hamilton,et al.  Development of a rating scale for primary depressive illness. , 1967, The British journal of social and clinical psychology.

[2]  C Krogh,et al.  "Compendium of pharmaceuticals and specialties". , 1983, Canadian Medical Association journal.

[3]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[4]  J. Mccombs,et al.  The cost of antidepressant drug therapy failure: a study of antidepressant use patterns in a Medicaid population. , 1990, The Journal of clinical psychiatry.

[5]  V. Velanovich.  Meta-analysis for combining Bayesian probabilities. , 1991, Medical hypotheses.

[6]  B Kinosian,et al.  Avoiding bias in the conduct and reporting of cost-effectiveness research sponsored by pharmaceutical companies. , 1991, The New England journal of medicine.

[7]  C. Clary,et al.  Placebo‐Controlled Trial of Venlafaxine for the Treatment of Major Depression , 1991, Journal of clinical psychopharmacology.

[8]  A S Detsky,et al.  How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. , 1992, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[9]  Szeinbach Sl,et al.  Formularies: the role of pharmacy-and-therapeutics (P&T) committees. , 1993 .

[10]  A. Rush.  Treatment of major depression , 1993 .

[11]  J. Feighner,et al.  Venlafaxine: a new dimension in antidepressant pharmacotherapy. , 1993, The Journal of clinical psychiatry.

[12]  J. Feighner,et al.  Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients. , 1994, The Journal of clinical psychiatry.

[13]  M. Bradley,et al.  Cumulative mean change procedure: Application to a comparative trial of venlafaxine, imipramine, and placebo in the treatment of major depression , 1994, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[14]  B. Diamond,et al.  A comparison of venlafaxine, trazodone, and placebo in major depression. , 1994, Journal of clinical psychopharmacology.

[15]  The emerging field of oral pharmaceuticals. , 1994, Journal of the American Dental Association.

[16]  S. Arikian,et al.  Rank-order Stability Analysis (ROSA) , 1995, Medical decision making : an international journal of the Society for Medical Decision Making.